Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells
about
Dickkopf-3/REIC functions as a suppressor gene of tumor growthInhibition of UV-C light-induced apoptosis in liver cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.Differentially profiling the low-expression transcriptomes of human hepatoma using a novel SSH/microarray approach.Next-generation sequencing of apoptotic DNA breakpoints reveals association with actively transcribed genes and gene translocations.Characterization of splice variants of human caspase-activated DNase with CIDE-N structure and function.A unique role of the DNA fragmentation factor in maintaining genomic stability.Identification of two contiguous minimally deleted regions on chromosome 1p36.31-p36.32 in oligodendroglial tumours.Stable overexpression of DNA fragmentation factor in T-47D cells: sensitization of breast cancer cells to apoptosis in response to acetazolamide and sulfabenzamide.Sensitization of breast cancer cells to doxorubicin via stable cell line generation and overexpression of DFF40.A novel interaction of nucleophosmin with BCL2-associated X protein regulating death evasion and drug sensitivity in human hepatoma cells.Involvement of hepatitis B virus X gene (HBx) integration in hepatocarcinogenesis via a recombination of HBx/Alu core sequence/subtelomeric DNA.siRNA-mediated knock-down of DFF45 amplifies doxorubicin therapeutic effects in breast cancer cells.
P2860
Q28290751-D3B9F779-A719-4F8A-87A9-8E06E5C04F69Q29347024-2DD3386C-E005-40F1-810A-97791D9F36A4Q33245282-B46D4BFD-4589-4D9D-A6FD-374A4BED47BAQ34075399-7199A05F-C7F5-44FD-B5E2-1832C90D5847Q34321342-8674C4BA-3B9E-4DE8-8CE2-3E660FB85208Q34334864-4464FD64-EA7E-4BC9-90E8-5C8DD862F754Q37355478-2D3BFCB6-D369-4A8D-A091-850DE7A3B354Q37554712-2E7FB5BB-18C8-45C9-8CB2-6DF54661648EQ37562199-18950D1B-EBE4-41B9-BDFF-CB2EC727DEB8Q39222607-E47A8126-7394-4AEE-8872-2B4B2F0DCA37Q39318333-FD9743FD-894F-4B6E-AB86-327DFF0B166CQ51770322-241038E9-DC9B-40E8-940C-E0EB444BBEA9
P2860
Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells
@ast
Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells
@en
Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells
@nl
type
label
Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells
@ast
Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells
@en
Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells
@nl
prefLabel
Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells
@ast
Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells
@en
Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells
@nl
P2093
P2860
P356
P1476
Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells
@en
P2093
P2860
P2888
P356
10.1038/SJ.BJC.6600695
P407
P577
2003-01-27T00:00:00Z
P5875
P6179
1002448021